Table 3 Calculated diagnosed prevalent cases and crude prevalence of AL amyloidosis since diagnosis, by country

79

284

406

497

9.12

32.92

47.14

57.70

101

364

521

638

8.77

31.63

45.27

55.40

64

234

337

415

9.15

33.28

47.90

58.92

38

136

196

242

9.02

32.76

47.18

58.01

8

30

43

52

7.01

25.11

35.59

42.99

92

331

473

577

8.67

31.32

44.81

54.62

50

182

261

319

8.80

31.83

45.57

55.68

11

41

59

72

8.63

31.25

44.88

55.10

52

187

267

327

9.29

33.60

48.10

58.85

586

2112

3025

3711

8.99

32.39

46.39

56.92

815

2950

4232

5203

10.11

36.62

52.53

64.59

106

385

552

676

9.78

35.40

50.74

62.19

83

300

431

529

8.49

30.74

44.14

54.18

3

9

13

16

7.43

26.74

38.17

46.43

34

123

176

213

7.17

25.77

36.77

44.48

620

2235

3197

3909

10.37

37.37

53.48

65.38

17

62

89

111

8.75

31.84

46.04

57.10

0

1

2

2

9.17

33.12

47.44

58.09

24

88

128

158

8.62

31.38

45.28

56.10

4

16

23

28

7.58

27.23

38.57

46.53

4

14

20

24

9.00

32.56

46.58

56.41

153

554

793

969

8.98

32.45

46.44

56.72

43

154

220

268

7.97

28.67

40.85

49.77

314

1133

1619

1978

8.16

29.41

42.04

51.34

100

362

521

636

9.76

35.41

50.93

62.16

165

599

861

1058

8.64

31.36

45.06

55.37

41

148

212

259

7.58

27.32

39.01

47.60

19

68

98

119

9.13

32.98

47.21

57.56

430

1551

2223

2704

9.32

33.62

48.20

58.64

89

322

462

566

8.93

32.27

46.24

56.67

555

2002

2863

3504

8.42

30.37

43.43

53.16

1126

4018

5684

6859

5.29

18.88

26.70

32.22

312

1118

1589

1927

8.43

30.25

43.00

52.15

1402

5070

7279

8938

11.15

40.33

57.89

71.08

1040

3759

5380

6545

7.26

26.24

37.55

45.69

399

1434

2034

2454

7.85

28.17

39.95

48.22

185

665

945

1142

7.86

28.24

40.13

48.52

2552

9175

13,074

15,923

7.76

27.90

39.76

48.42

11,716

42,217

60,307

73,567

8.17

29.42

42.03

51.27